As reported previously (Sep 2018) Israel’s Orthospin is a smart, robotic, self-adjusting, external fixation system for helping heal bones after complex orthopedic operations. Orthospin has now received US FDA approval. http://israelbetweenthelines.com/2020/01/02/orthopedic-technology-improves-painful-medical-process/ https://www.prnewswire.com/news-releases/orthospin-receives-fda-regulatory-clearance-300920687.html

As reported previously (see here) Israel-based Augmedics has developed xvision – an augmented reality X-ray-like headset for surgeons to use in spinal and pelvic operations. Xvision has just received US FDA clearance. https://www.calcalistech.com/ctech/articles/0,7340,L-3776433,00.html

Israel’s aMoon fund, has invested $5 million in the new NanoGhost anti-cancer therapy of Technion Professor Marcelle Machluf. (reported here previously). In lab tests NanoGhost reduced small lung carcinoma, prostate, and pancreatic cancer tumors, by as much as 85%. https://www.timesofisrael.com/ghost-cell-startup-that-targets-deadliest-cancers-gets-funding-boost

The Nerivio migraine-zapping wearable device from Israel’s Theranica has already been reported (see here) as one of Time Magazine’s 100 Best Inventions for 2019. Now it has been selected by US research company CB Insights as one of 36 game-changing … Continue reading →

The Israel Cancer Research Fund (ICRF) has given $72 million for Israeli cancer research. Much of this is used by scientists to develop treatments that alleviate the damage from chemotherapy, radiation and immunotherapy.  Several examples are given in this link. … Continue reading →